ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

21,10
0,88
(4,35%)
Geschlossen 05 Februar 10:00PM
20,15
-0,95
(-4,50%)
Nach Börsenschluss: 1:41AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
20,15
Gebot
20,00
Fragen
21,10
Volumen
968.803
20,215 Tagesbereich 21,20
5,12 52-Wochen-Bereich 21,56
Marktkapitalisierung
Handelsende
20,22
Handelsbeginn
20,2475
Letzte Trade
22
@
21.1
Letzter Handelszeitpunkt
Finanzvolumen
US$ 20.154.329
VWAP
20,8033
Durchschnittliches Volumen (3 Mio.)
1.215.764
Ausgegebene Aktien
78.049.928
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-14,78
Gewinn pro Aktie (EPS)
-1,43
Erlöse
145,24M
Nettogewinn
-111,4M

Über Travere Therapeutics Inc

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Lewes, Delaware, USA
Gegründet
-
Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was US$20,22. Over the last year, Travere Therapeutics shares have traded in a share price range of US$ 5,12 to US$ 21,56.

Travere Therapeutics currently has 78.049.928 shares in issue. The market capitalisation of Travere Therapeutics is US$1,58 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -14.78.

TVTX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.02-0.099157164105120.1721.419.67113932520.67123294CS
41.296.8398727465518.8621.5616.8121051519.34790709CS
121.397.4093816631118.7621.5616.588121576418.49360475CS
2612.16152.1902377977.9921.567.95151869215.83041479CS
5211.83142.18758.3221.565.12135469212.19009824CS
156-5.85-22.52630.355.12122733815.26026436CS
260-5-19.880715705825.1533.08995.12108506516.64327721CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is US$ 20,15
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 78.049.928 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1,58B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of US$ 5,12 to US$ 21,56 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -14,78
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 11,33
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 145,24M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -111,4M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CAPTCaptiVision Inc
US$ 1,024
(133,26%)
246M
QNTMQuantum Biopharma Ltd
US$ 6,70
(110,69%)
78,56M
LTRYLottery com Inc
US$ 0,58
(85,90%)
129,21M
CPIXCumberland Pharmaceutical Inc
US$ 3,7801
(77,47%)
18,49M
INKTMiNK Therapeutics Inc
US$ 12,08
(53,69%)
350,86k
OMGAOmega Therapeutics Inc
US$ 0,1473
(-69,25%)
11,71M
VIRXViracta Therapeutics Inc
US$ 0,0352
(-54,76%)
6,33M
CYNCYNGN Inc
US$ 0,0708
(-39,44%)
137,42M
UPCUniverse Pharmaceuticals Inc
US$ 0,2663
(-36,20%)
1,9M
CSAICloudastructure Inc
US$ 12,98
(-31,68%)
57,03k
NVDANVIDIA Corporation
US$ 118,65
(1,71%)
256,77M
CAPTCaptiVision Inc
US$ 1,024
(133,26%)
246M
PLTRPalantir Technologies Inc
US$ 103,83
(23,99%)
230,5M
RGTIRigetti Computing Inc
US$ 13,71
(1,78%)
159,64M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1518
(-22,11%)
142,77M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht